Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL30853200 | 0.92 | ALDH1A1 (0.53) | TSHRTDP1ALDH1A1L3MBTL1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL39465 | 0.92 | ALDH1A1 (0.50) | TSHRTDP1ALDH1A1L3MBTL1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL295 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3950101 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3507077 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL25292545 | 0.88 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL25292879 | 0.88 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL20138552 | 0.88 | ALDH1A1 (0.47) | TSHRTDP1ALDH1A1L3MBTL1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL25293988 | 0.88 | ALDH1A1 (0.47) | TSHRTDP1ALDH1A1L3MBTL1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL1287800 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100331599-A1 | ALKYLATION CATALYZED BY BINARY MIXTURES OF ACID AND IONIC LIQUID | SUBRAMANIAM BALA | 2010-12-30 | — | — | US | claimed |
| US-9624248-B2 | Ionic liquid compound | RELIANCE INDUSTRIES LIMITED (IN) | 2017-04-18 | — | — | US | disclosed |
| US-20160060277-A1 | IONIC LIQUID COMPOUND | RELIANCE INDUSTRIES LIMITED (IN) | 2016-03-03 | — | — | US | disclosed |
| CN-1138546-C | Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine | ʷ��˿�������ȳ�ķ����˾ | 2004-02-18 | — | — | CN | disclosed |
| CN-1177299-A | Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine | SMITHKLINE BEECHAM CORP (US) | 1998-03-25 | — | — | CN | disclosed |
| US-5262562-A | Catalyst is fluorosulfonic acid treated montmorillonite | TEXACO CHEMICAL COMPANY (US) | 1993-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331599-A1 | ALKYLATION CATALYZED BY BINARY MIXTURES OF ACID AND IONIC LIQUID | BPTF, BPGM, MPST | TSHR 206/4885TDP1 3423/4885ALDH1A1 2619/4885 |
| US-20160060277-A1 | IONIC LIQUID COMPOUND | GRIK1, INSR, GRIK2 | TSHR 1251/4885TDP1 4666/4885ALDH1A1 494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.